161 related articles for article (PubMed ID: 22331039)
1. Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma.
Mir O; Boudou-Rouquette P; Larousserie F; Blanchet B; Babinet A; Anract P; Goldwasser F
Anticancer Drugs; 2012 Aug; 23(7):745-8. PubMed ID: 22331039
[TBL] [Abstract][Full Text] [Related]
2. Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma.
Azizi AA; Haberler C; Czech T; Gupper A; Prayer D; Breitschopf H; Acker T; Slavc I
Lancet Oncol; 2006 Jun; 7(6):521-3. PubMed ID: 16750504
[No Abstract] [Full Text] [Related]
3. Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Hanzer M; Nebl A; Spendel S; Pilhatsch A; Urban C; Benesch M
Klin Padiatr; 2010 May; 222(3):184-6. PubMed ID: 20514624
[TBL] [Abstract][Full Text] [Related]
4. Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib.
Ghose A; Tariq Z; Veltri S
Am J Ther; 2012 Jan; 19(1):e56-8. PubMed ID: 20634674
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.
Conde N; Cruz O; Albert A; Mora J
Pediatr Blood Cancer; 2011 Dec; 57(6):1071-3. PubMed ID: 21744483
[TBL] [Abstract][Full Text] [Related]
6. Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent® treatment an effective approach?
Hilbert M; Mary P; Larroquet M; Serinet MO; Helfre S; Brisse H; Coulomb A; Orbach D
Pediatr Blood Cancer; 2012 Mar; 58(3):475-6. PubMed ID: 22234817
[No Abstract] [Full Text] [Related]
7. Advanced alveolar soft part sarcoma responds to apatinib.
Zhou Y; Tang F; Wang Y; Min L; Luo Y; Zhang W; Shi R; Duan H; Tu C
Oncotarget; 2017 Jul; 8(30):50314-50322. PubMed ID: 28679123
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.
Jagodzińska-Mucha P; Świtaj T; Kozak K; Koseła-Paterczyk H; Klimczak A; Ługowska I; Rogala P; Wągrodzki M; Falkowski S; Rutkowski P
Tumori; 2017 May; 103(3):231-235. PubMed ID: 28291905
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
Ye C; Wang J; Li W; Yuan M; Chai Y
Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract][Full Text] [Related]
11. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
13. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
[TBL] [Abstract][Full Text] [Related]
14. [A rare tumour with a distinctive histological appearance].
Pavageau AH; Croué A; Reguerre Y; Rialland X; Rousselet MC
Ann Pathol; 2010 Apr; 30(2):152-4. PubMed ID: 20451077
[No Abstract] [Full Text] [Related]
15. [Clinical features and prognosis of alveolar soft part sarcoma].
Xu LB; Yu SJ; Shao YF; Zhang HT; Zhao ZG
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):778-80. PubMed ID: 18396693
[TBL] [Abstract][Full Text] [Related]
16. [Antiangionic drugs in soft tissue sarcoma].
Salas S; Huynh T; Deville JL; Duffaud F
Bull Cancer; 2010 Jun; 97(6):701-5. PubMed ID: 20483703
[TBL] [Abstract][Full Text] [Related]
17. Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
Cohen JW; Widemann BC; Derdak J; Dombi E; Goodwin A; Dompierre J; Onukwubiri U; Steinberg SM; O'Sullivan Coyne G; Kummar S; Chen AP; Glod J
Pediatr Blood Cancer; 2019 Dec; 66(12):e27987. PubMed ID: 31502400
[TBL] [Abstract][Full Text] [Related]
18. Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
Su H; Yu C; Ma X; Song Q
Invest New Drugs; 2021 Oct; 39(5):1411-1418. PubMed ID: 33765213
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T; Lindley C
Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
[TBL] [Abstract][Full Text] [Related]
20. Metastatic alveolar soft part sarcoma presenting as a dural-based cerebral mass.
Perry JR; Bilbao JM
Neurosurgery; 1994 Jan; 34(1):168-70. PubMed ID: 8121554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
